Detalhe da pesquisa
1.
Breadth of Fc-mediated effector function correlates with clinical immunity following human malaria challenge.
Immunity
; 57(6): 1215-1224.e6, 2024 Jun 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38788711
2.
Full-length MSP1 is a major target of protective immunity after controlled human malaria infection.
Life Sci Alliance
; 7(8)2024 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-38803222
3.
Multifunctional IgG/IgM antibodies and cellular cytotoxicity are elicited by the full-length MSP1 SumayaVac-1 malaria vaccine.
NPJ Vaccines
; 8(1): 112, 2023 Aug 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37558673
4.
Characterization of a novel Plasmodium falciparum merozoite surface antigen and potential vaccine target.
Front Immunol
; 14: 1156806, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37122725
5.
Anti-merozoite antibodies induce natural killer cell effector function and are associated with immunity against malaria.
Sci Transl Med
; 15(682): eabn5993, 2023 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36753561
6.
Phagocytosis of Plasmodium falciparum ring-stage parasites predicts protection against malaria.
Nat Commun
; 13(1): 4098, 2022 07 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35835738
7.
Cercarial Behavior Determines Risk of Predation.
J Parasitol
; 105(2): 330-333, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31021737
8.
KILchip v1.0: A Novel Plasmodium falciparum Merozoite Protein Microarray to Facilitate Malaria Vaccine Candidate Prioritization.
Front Immunol
; 9: 2866, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30619257